alexa Measuring Serum Uric Acid Level in Terms of Preanalytics for Public Health | Open Access Journals
ISSN: 2161-1009
Biochemistry & Analytical Biochemistry
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Measuring Serum Uric Acid Level in Terms of Preanalytics for Public Health

Nilgün Tekkesin*

Memorial Hospital, Biochemistry Laboratory, Istanbul, Turkey

*Corresponding Author:
Nilg¨n Tekkesin
Memorial Hospital
Biochemistry Laboratory
Istanbul, Turkey
E-mail: [email protected]

Received Date: September 13, 2012; Accepted Date: September 13, 2012; Published Date: September 16, 2012

Citation: Tekkesin N (2012) Measuring Serum Uric Acid Level in Terms of Preanalytics for Public Health. Biochem Anal Biochem 1:e117. doi:10.4172/2161-1009.1000e117

Copyright: © 2012 Tekkesin N. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Biochemistry & Analytical Biochemistry

Uric acid (UA) is the final product of purine catabolism. For many years, UA has been used in clinical practice as a marker of several metabolic disturbances, although until recently its antioxidant properties had not been considered. UA is the most abundant aqueous antioxidant in humans, and contributes as much as two-thirds of all free radical scavenging capacity in plasma. The plasma concentration of UA is almost 10-fold higher than other antioxidants, such as vitamin C and vitamin E [1]. Moreover, UA has much higher antioxidant capacity [2].It is particularly effective in quenching hydroxyl, superoxide and peroxynitrite radicals, and may serve a protective physiological role by preventing lipid peroxidation [3]. In a variety of organs and vascular beds, local UA concentrations increase during acute oxidative stress and ischaemia, and the increased concentrations might be a compensatory mechanism that confers protection against increased free radical activity [4].

Excess serum accumulation of UA defined as hyperuricemiacan lead to various diseases, and most notably UA is causally involved in the pathogenesis of gouty arthritis. Recently, gout has been linked to cardiovascular disease. Epidemiological data supports the strong association between cardiovascular disease and gout [5-7]. Also, a number of epidemiological reports have increasingly linked hyperuricemia with neurological diseases [8].UA can act as a prooxidant, particularly at increased concentrations, and may thus be a marker of oxidative stress [9], but it may also have a therapeutic role as an antioxidant [10].

UA’s contribution to atherosclerotic vascular disease, however, is still somewhat controversial. Over recent years, increasing attention has been paid to its potential role in the disease manifestations that ensue. It is unclear whether high UA concentrations promote or protect against the development of cardiovascular disease, or simply act as a passive marker of increased risk. Despite the widely held view that elevated serum UA concentrations confer increased risk of atherosclerotic disease, there is no compelling biological evidence of a causal link. Free radical activity is characteristically increased in patients with any one of several major cardiovascular risk factors, and is thought to play a key role in the early development of atherosclerosis. Ongoing basic research is likely to shed new light on the cardiovascular effects of UA, and will hopefully allow the significance of serum concentrations to be interpreted more clearly.

Measurement of US might be a need in terms of preanalytics, The analyse is inexpensive and can be performed with simple methods in routine laboratories. Thus, it should be stated as a preventive, costeffective approach for public health. High-risk groups need to be studied in more detail, and a randomized controlled trial to test the effect of UA reduction on clinical end points may be warranted [9]. Patients with advanced atherosclerotic disease may present an even more attractive group, with a potentially larger benefit from intervention, than subjects from the general population. We might use uric acid as a new candidate to fascilate changes in therapy as developments in medicine are not always straightforward.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Article Usage

  • Total views: 11464
  • [From(publication date):
    October-2012 - Oct 22, 2017]
  • Breakdown by view type
  • HTML page views : 7711
  • PDF downloads :3753
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords